Search result for 'pharma industry'

India's CRDMO sector is poised for significant growth, with potential to reach USD 25 billion by 2035, driven by de-risking supply chains and rising demand for advanced modalities.

Zydus Lifesciences Chairman Pankaj R Patel believes India can deliver 100 new drugs by 2047, emphasizing the need for innovation and societal benefit. Read more.

Union Minister Jitin Prasada hails the 2025-26 Budget as historic, praising its focus on the middle class and income tax exemption. The opposition, he says, failed to find flaws to criticize.

Piyush Goyal stresses the importance of innovation for the Indian pharmaceutical industry, warning that without it, the industry will be finished. He urges firms to focus on research and...

Torrent's Samir Mehta envisions India as the world's healthcare custodian, aiming to double the pharma industry's size by 2030. Discover the growth strategy and key enablers for this ambitious goal.

India's pharmaceutical industry is poised for a dramatic transformation by 2025, driven by AI, machine learning, and precision medicine. Discover how innovation, global access, and quality...

The 17th CPHI & PMEC India Expo will showcase the latest advancements in pharmaceutical modernization, innovation, and sustainability, featuring over 2,000 exhibitors and 10,000 products. Held in...

The 17th CPHI & PMEC India Expo, held Nov 26-28 in Greater Noida, showcases pharma innovation, sustainability, and modernization. Over 2,000 exhibitors from around the world will display...

Commerce Minister Piyush Goyal urges Indian industry to prioritize quality over government subsidies for export competitiveness, highlighting the importance of Quality Control Orders (QCOs) and...

India's pharmaceutical and meditech exports are expected to continue strong growth despite global economic slowdown, driven by government support and a pipeline of blockbuster molecules.

The Organisation of Pharmaceutical Producers of India (OPPI) has appointed Bhushan Akshikar as its President for two years. Akshikar brings over 28 years of experience in the pharmaceutical industry.

India's Production-Linked Incentive (PLI) scheme for pharma and medical devices is driving growth, with 50 new plants planned in the next two years.

India's pharma sector, valued at USD 50 billion, is projected to reach USD 130 billion by 2030. Economic Survey highlights the need for skill development, innovation, and a robust supply chain for...

Indian pharma industry set to benefit from USD 10 billion opportunity in off-patent drugs by 2029, with blockbuster drugs like Pembrolizumab and Eliquis going off-patent. Learn more about the...

India's interim budget focuses on strengthening the healthcare sector, promoting bulk drug manufacturing, and enhancing nutrition programs. The allocation of Rs 90,658.63 crore for health and the...

The Indian government has allocated Rs 1,000 crore for promoting bulk drug parks in FY25, a significant increase from the previous fiscal. This move aims to boost the pharmaceutical industry.

Goa CM highlights state's attractiveness to global investors across sectors at Invest Goa 2024, emphasizing infrastructure, policies, and skilled workforce.

Biocon's Kiran Mazumdar-Shaw says research-based incentives for innovative drugs can boost India's pharma industry to USD 200 billion by 2030, highlighting the need for drug innovation and digital...

The Indian pharma industry seeks fiscal incentives and conducive policies to promote R&D and reach USD 450 billion market size by 2047. The industry calls for a focus on innovation and easing...

India's pharma industry expects sustained growth in 2024, focusing on quality, innovation, and collaboration to meet evolving healthcare needs.

Gujarat boasts over 4,000 pharma manufacturing units, contributing significantly to India's pharma production and exports. Learn more about its dominance in the sector.